Cardiac and Renal Dysfunction in Chronic Heart Failure: Relation to Neurohumoral Activation and Prognosis

BackgroundIn chronic heart failure (CHF), cardiac dysfunction is considered the major determinant of neurohumoral activation but the role of renal impairment has not been defined. We investigated the relationship between both cardiac and renal dysfunction and neurohumoral activation, and their possible influence on prognosis. MethodsHemodynamics, renal function, plasma neurohormones, and long-term follow-up were evaluated in 148 CHF patients, grouped according to systolic volume index (SVI) and serum creatinine (CRE) values: SVI > 28 mL/m2 and CRE < 1.5 mg/dL (group I, n = 55), SVI < 28 mL/m2 and CRE < 1.5 mg/dL (group II, n = 37), SVI > 28 mL/m2 and CRE > 1.5 mg/dL (group III, n = 25), SVI < 28 mL/m2 and CRE > 1.5 mg/dL (group IV, n = 31). ResultsNeurohormones progressively increased from Group I through IV and correlated with both cardiac and renal function. The hemodynamic pattern was similar in patients with normal or abnormal renal function, whereas neurohormones were only moderately increased in the former group and markedly increased in the latter group. Long-term survival progressively decreased from Group I through IV and was significantly poorer in patients with renal dysfunction. ConclusionsOur study confirms that, in CHF, neurohumoral activation is strictly related to long-term survival and that many factors contribute to its development and progression; among these, cardiac and renal dysfunction seem to play a major role.

[1]  Marenzi,et al.  The noradrenaline plasma concentration and its gradient across the lung , 2000, European journal of clinical investigation.

[2]  S. Chugh,et al.  Mechanisms and management of renal dysfunction in heart failure. , 1997, Current opinion in cardiology.

[3]  S. Yusuf,et al.  Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators. , 1994, Journal of the American College of Cardiology.

[4]  J. Hansen,et al.  Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. , 1994, European heart journal.

[5]  R. Cody Clinical trials of diuretic therapy in heart failure: research directions and clinical considerations. , 1993, Journal of the American College of Cardiology.

[6]  W. Stevenson,et al.  Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[7]  J. Cohn,et al.  Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II , 1993, Circulation.

[8]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[9]  M. Guazzi,et al.  Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. , 1993, The American journal of medicine.

[10]  J Keegan,et al.  Predictors of prognosis in severe chronic heart failure. , 1992, American heart journal.

[11]  M. A. Plant Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality , 1991 .

[12]  W. Abraham,et al.  Elevated plasma noradrenaline concentrations in patients with low-output cardiac failure: dependence on increased noradrenaline secretion rates. , 1990, Clinical science.

[13]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[14]  J. Rouleau,et al.  Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. , 1989, The American journal of cardiology.

[15]  M. Gheorghiade,et al.  Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[16]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[17]  P A Poole-Wilson,et al.  Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. , 1989, Circulation.

[18]  S. Shimai [The usefulness of the cardio-renal subset to predict early prognosis in acute myocardial infarction]. , 1988, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[19]  K. Badr,et al.  Prerenal failure: a deleterious shift from renal compensation to decompensation. , 1988, The New England journal of medicine.

[20]  M. Packer,et al.  Neurohormonal interactions and adaptations in congestive heart failure. , 1988, Circulation.

[21]  R. Schrier Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) , 1988, The New England journal of medicine.

[22]  I Ford,et al.  Mortality in heart failure: clinical variables of prognostic value. , 1987, British heart journal.

[23]  M. Pepi,et al.  Pulmonary vascular supersensitivity to catecholamines in systemic high blood pressure. , 1986, Journal of the American College of Cardiology.

[24]  J. Rouleau,et al.  Sodium and water excretion abnormalities in congestive heart failure. Determinant factors and clinical implications. , 1986, Annals of internal medicine.

[25]  R. Cody,et al.  Sodium and water balance in chronic congestive heart failure. , 1986, The Journal of clinical investigation.

[26]  M. Packer,et al.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.

[27]  K. Swedberg,et al.  Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. , 1985, The American journal of medicine.

[28]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[29]  J. Cohn,et al.  The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.

[30]  J. Cohn,et al.  Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[31]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[32]  F. Magrini,et al.  Circulatory and renin responses in man to unilateral reduction of the renal perfusion pressure. , 1981, Cardiovascular research.

[33]  N. Hollenberg,et al.  Relation of the Renin‐Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure , 1981, Circulation.

[34]  J. Cohn,et al.  Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure , 1978, Circulation.

[35]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[36]  P. Cannon The kidney in heart failure. , 1977, The New England journal of medicine.

[37]  N. Varsano-Aharon,et al.  A simplified radioimmunoassay of plasma aldosterone. , 1973, The Journal of clinical endocrinology and metabolism.

[38]  A. Barger RENAL HEMODYNAMIC FACTORS IN CONGESTIVE HEART FAILURE * , 1966, Annals of the New York Academy of Sciences.

[39]  W. Youmans Renal function in congestive heart failure. , 1954, Annals of internal medicine.